Marex Group ($MRX) Investor Settlement

The parties have reached an agreement to settle the case, but the terms are still being finalized. You can submit your application now, and it will be processed once claims filing opens.

S.D. New York

Court

1:25-cv-08393

Case number

05/16/2024

Class period Start

08/05/2025

Class period End

Marex Group has reached a tentative settlement to resolve investor claims that it misled the market about its financial trajectory ahead of its 2025 IPO.

Outline:

In its IPO registration documents, Marex touted record 2024 performance driven by strong commodities trading and a diversified revenue mix. Investors say the company already knew net revenue and EBITDA were trending below internal forecasts before the IPO closed. On August 6, 2025, Marex reported Q2 net revenue down 8.2% and adjusted EBITDA down 47% year-over-year, and $MRX fell 36.4%. The case has now moved to a tentative settlement.

Timeline:
June 27, 2025: Marex completed its U.S. IPO, offering 15.4 million shares at $19.50, and began trading under $MRX.
August 6, 2025: Marex released Q2 2025 earnings showing net revenue of $335.3M, $MRX fell 36.4% from its IPO-day close.
June 10, 2026: The parties agreed to a tentative settlement.
Background:

Marex Group completed its U.S. IPO on June 27, 2025, offering 15.4 million shares at $19.50 and beginning to trade under the ticker $MRX. In its registration documents, the company highlighted record 2024 performance, pointing to robust commodities trading, expansion into clearing and derivatives, and a diversified revenue mix.

Investors say those offering documents omitted key facts about Marex's financial condition heading into Q2 2025. According to the case, Marex knew net revenue and EBITDA were already trending below internal forecasts before the IPO closed, but did not disclose this to the market.

On August 6, 2025, just six weeks after the IPO, Marex released Q2 2025 earnings showing net revenue of $335.3M, down 8.2% from Q2 2024, and adjusted EBITDA of $41.3M, a 47% drop year-over-year — both significantly below consensus expectations. The company also issued a weaker outlook for the second half of the year, citing low volatility and softer trading conditions.

Following this report, $MRX fell 36.4% from its IPO-day close to August 6, 2025, wiping out hundreds of millions in investor capital. The dispute centers on claims that Marex presented a bullish growth narrative in its IPO documents while already aware that performance was deteriorating. The case has now moved to a tentative settlement.

What Can Investors Expect Now?

Marex Group has reached a tentative settlement to resolve investor claims tied to alleged misrepresentations in its 2025 IPO registration statement.

If you were damaged due to this situation, you can file for a payout and get your share of the settlement. You can check if you are eligible and other details in the FAQ section.

Case Type

US Securities Class Action

Case Status

Tentative Settlement

Alleged Offence

Financial Misrepresentation,

Fraud

Suspected Party

Management

Security Type

Stocks

Trade Direction

Long

Filing date

10/09/2025

Lead Plaintiff Deadline

12/08/2025

Plaintiffs

Ravishanker Narayanan

Attorneys

Glancy Prongay & Murray LLP

Defendants

Ian Lowitt ; Robert Irvin

Trades matching type

FIFO